Sign in

CIK 0001527599

  • Non-accelerated filer
  • Smaller reporting company

SYNLOGIC, INC.

Sign in to watch
Ticker
SYBX
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
261824804
Phone
+1 617-659-2802
Business address
PO BOX 30, WINCHESTER, MA, 01890
Former names
Mirna Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-10-05 Winkler Matthew Director Conversion +134,958 134,958
2015-10-05 Winkler Matthew Director Conversion +28,458 163,416
2015-10-05 Winkler Matthew Director Conversion +235,899 399,315
2015-10-05 Winkler Matthew Director Conversion +187,277 586,592
2015-10-05 Winkler Matthew Director Conversion +2,345 2,345
2015-10-05 Winkler Matthew Director Conversion +40,281 42,626
2015-10-05 Winkler Matthew Director Conversion +2,345 2,345
2015-10-05 Winkler Matthew Director Conversion +40,281 42,626
2015-10-05 Winkler Matthew Director Conversion +2,345 2,345
2015-10-05 Winkler Matthew Director Conversion +40,281 42,626
2015-10-05 Winkler Matthew Director Conversion · Series A Preferred Stock −134,958 0
2015-10-05 Winkler Matthew Director Conversion · Series A Preferred Stock −2,345 0
2015-10-05 Winkler Matthew Director Conversion · Series A Preferred Stock −2,345 0
2015-10-05 Winkler Matthew Director Conversion · Series A Preferred Stock −2,345 0
2015-10-05 Winkler Matthew Director Conversion · Series B Preferred Stock −28,458 0
2015-10-05 Winkler Matthew Director Conversion · Series C Preferred Stock −235,899 0
2015-10-05 Winkler Matthew Director Conversion · Series C Preferred Stock −40,281 0
2015-10-05 Winkler Matthew Director Conversion · Series C Preferred Stock −40,281 0
2015-10-05 Winkler Matthew Director Conversion · Series C Preferred Stock −40,281 0
2015-10-05 Winkler Matthew Director Conversion · Series D Preferred Stock −187,277 0

Page 17 of 18 · 358 trades